Hemophilia A

5 protocols meet the specified criteria

OCR14675

Phase 3, prospective, multi-center, open label study to investigate safety, immunogenicity, and hemostatic efficacy of PEGylated Factor VIII (BAX 855) in previously untreated patients (PUPs) < 6 years with severe hemophilia A (FVIII < 1%)

OCR15074

A randomized, multicenter, open-label, phase iii clinical trial to evaluate the efficacy, safety, and pharmacokinetics of prophylactic Emicizumab versus no prophylaxis in hemophilia a patients age >= 12 years without FVIII inhibitors

OCR15295

TAURUS: A Multinational Phase IV Study Evaluating "Real World" Treatment Pattern in Previously Treated Hemophilia A Patients Receiving KOVALTRY (Octocog Alfa) for Routine Prophylaxis

OCR15335

Evaluation of Joint Arthropathy Using Ultrasound Technique in Children With Severe Hemophilia Undergoing Prophylaxis Regimen

OCR17544

A Phase IV Multicenter, Single-Arm, Open Label Study of Emicizumab Prophylaxis in Patients with Hemophilia A and Inhibitors Undergoing Minor Surgical Procedures.